Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    " May 05, 2010":" June 04, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Selective Exposure in HIV Prevention
Condition: HIV Infections
Interventions: Other: Instrumental meta intervention;   Other: Empowering meta-intervention;   Other: Control
22 Completed Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data
Condition: HIV Infections
Intervention:
23 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel
24 Completed Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children
Condition: HIV
Intervention: Biological: valent pneumococcal conjugated vaccine
25 Unknown  Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children
Condition: HIV-1 Infection
Intervention: Other: lopinavir/ritonavir
26 Completed Risk Reduction Intervention for Vulnerable Young Adult Males
Conditions: Sex;   Substance Use;   HIV
Intervention: Behavioral: HIV prevention intervention randomized control trial
27 Completed HIV Testing in Non-traditional Settings Study
Condition: HIV
Interventions: Other: Questionnaire;   Other: Focus Group Discussion;   Other: HIV test (serum or salivary);   Other: Semi-structured telephone interview
28 Completed Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Conditions: Coronary Heart Disease;   Heart Failure;   HIV;   AIDS;   Metabolic Syndrome
Intervention: Other: Comprehensive non invasive cardiovascular examination
29 Completed Lopinavir (LPV) Dose Reduction
Condition: HIV-1 Infections
Interventions: Drug: Generic LPV/r and Aluvia (pharmacokinetics);   Drug: Aluvia and Generic LPV/r (pharmacokinetics)
30 Completed Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
Condition: HIV
Intervention:
31 Completed Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi
Condition: HIV
Interventions: Drug: Copper IUD;   Drug: Depo Medroxyprogesterone acetate
32 Active, not recruiting Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
Conditions: Drug Abuse;   HIV Risk Behavior
Interventions: Behavioral: Computerized brief intervention;   Behavioral: Counselor delivered brief intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years